Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net earnings	$ 480.0	$ 847.7	$ 933.1
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	1,523.0	1,032.1	566.6
Deferred income tax benefit	(609.5)	(115.9)	(315.2)
Litigation settlements and other contingencies, net	597.7	15.1	7.4
Losses on acquisition-related foreign currency derivatives	128.6	0.0	0.0
Loss from equity method investments	112.8	105.1	91.4
Stock-based compensation expense	88.9	92.8	66.0
Write off of financing fees	35.8	99.6	0.0
Other non-cash items	499.4	263.2	139.1
Changes in operating assets and liabilities:
Accounts receivable	(131.8)	65.8	(231.2)
Inventories	(279.3)	(320.4)	(147.5)
Trade accounts payable	87.7	131.8	(0.3)
Income taxes	37.5	(164.2)	78.5
Other operating assets and liabilities, net	(523.6)	(44.2)	(173.1)
Net cash provided by operating activities	2,047.2	2,008.5	1,014.8
Cash flows from investing activities:
Cash paid for acquisitions, net	(6,481.9)	(693.1)	(50.0)
Capital expenditures	(390.4)	(362.9)	(325.3)
Payments for product rights and other, net	(360.2)	(506.5)	(420.2)
Cash paid for Meda's unconditional deferred payment	(308.0)	0.0	0.0
Settlement of acquisition-related foreign currency derivatives	(128.6)	0.0	0.0
Purchase of marketable securities	(30.2)	(62.1)	(19.9)
Change in restricted cash	57.1	21.8	(5.1)
Proceeds from sale of marketable securities	21.5	33.1	20.2
Net cash used in investing activities	(7,620.7)	(1,569.7)	(800.3)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	11,752.2	3,539.2	2,235.0
Payment of long-term debt	(6,296.3)	(4,484.1)	(2,295.8)
Payment of financing fees	(112.6)	(130.4)	(5.8)
Proceeds from convertible note hedge	0.0	1,970.8	0.0
Change in short-term borrowings, net	40.8	(329.2)	(107.8)
Purchase of common stock	0.0	(67.5)	0.0
Proceeds from exercise of stock options	13.8	97.7	53.8
Taxes paid related to net share settlement of equity awards	(17.5)	(31.8)	(27.7)
Contingent consideration payments	(35.5)	0.0	(150.0)
Acquisition of noncontrolling interest	(1.1)	(11.7)	0.0
Other items, net	0.8	51.8	30.9
Net cash provided by (used in) financing activities	5,344.6	604.8	(267.4)
Effect on cash of changes in exchange rates	(8.3)	(33.1)	(12.9)
Net (decrease) increase in cash and cash equivalents	(237.2)	1,010.5	(65.8)
Cash and cash equivalents — beginning of period	1,236.0	225.5	291.3
Cash and cash equivalents — end of period	998.8	1,236.0	225.5
Non-cash transactions:
Non-cash transactions		18.0
Ordinary shares issued for acquisition	1,281.7	6,305.8	0.0
Cash paid during the period for:
Income taxes	285.6	302.9	210.5
Interest	357.2	254.7	273.8
Other current liabilities
Non-cash transactions:
Non-cash transactions	$ 16.0	$ 18.0	$ 0.0